Cencora, Inc. · NYSE:COR

Cencora — AmerisourceBergen — Q2 2022 Earnings Presentation

14 slides from Cencora's earnings presentation, May 4, 2022

  1. Slide 1: Q2 FY2022 Financial Results

    Q2 FY2022 Financial Results May 4, 2022

  2. Slide 2: Cautionary note regarding forward-looking statements

    Cautionary note regarding forward-looking statements Certain of the statements contained in this press release are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Securi

  3. Slide 3: AmerisourceBergen is united in our responsibility to create healthier futures

    AmerisourceBergen is united in our responsibility to create healthier futures. AmerisourceBergen creates unparalleled access, efficiency, and reliability for human and animal health as a leading provider of pharmaceutical distribution services and differentiated value-added solutions for upstream an

  4. Slide 4: Overview

    Overview Recent highlights Global healthcare Fiscal 2022 guidance leader • Growth driven by strong • Foundation of leadership • Updated fiscal 2022 execution and in pharmaceutical guidance reflects stronger momentum across distribution than expected performance business • Complementary higher of sev

  5. Slide 5: Q2 FY2022 financial results: Consolidated results

    Q2 FY2022 financial results Consolidated results GAAP Adjusted (non-GAAP)1 Revenue $57.7B $57.7B % Change (Year-over-Year) 17.4% 17.4% Gross profit $2.2B $2.2B % Change 45.8% 46.6% Operating expenses $1.5B $1.3B % Change 60.1% 61.4% Operating income $780M $917M % Change 25.0% 29.7% Interest expense,

  6. Slide 6: U.S. Healthcare Solutions segment

    Q2 FY2022 financial results U.S. Healthcare Solutions segment Q2 FY2022 Q2 FY2021 YoY Change Revenue $50.9B $48.2B 5.8% Operating income $730M $655M 11.4% Percentages of revenue Gross profit 2.87% 2.73% Operating expenses 1.44% 1.37% Operating income 1.43% 1.36% ▪ U.S. Healthcare Solutions consists

  7. Slide 7: International Healthcare Solutions segment

    Q2 FY2022 financial results International Healthcare Solutions segment Q2 FY2022 Q2 FY2021 YoY Change Revenue, as reported $6.8B $989M 585.3% Revenue, constant currency $7.4B 650% Operating income, as reported $187M $52M 260.8% Operating Income, constant currency $227M 337% Percentages of revenue, a

  8. Slide 8: FY2022 guidance

    FY2022 guidance Updated guidance reflects stronger than expected performance in several businesses Revenue High-single to low-double digit percent growth U.S. Healthcare Solutions revenue $207 billion to $212 billion represents growth of 2% to 5% International Healthcare Solutions revenue $26 billio

  9. Slide 9: Creating differentiated value for our stakeholders

    Creating differentiated value for our stakeholders Our long-term, sustainable growth is supported by investments in our people and culture and commitment to ESG Why we exist We are united in our responsibility to create healthier futures Our areas of focus Specialty medicine Community providers Cust

  10. Slide 10: Advancing environmental, social, and governance initiatives to create healthier futures

    Advancing environmental, social, and governance initiatives to create healthier futures around the world ENVIRONMENTAL SOCIAL Adapting to a changing climate Investing in our people and communities • Reduced greenhouse gas emissions by 10.5% • Long-term diversity, equity, and inclusion in fiscal 2020

  11. Slide 11: Appendix

    Appendix

  12. Slide 12: Non-GAAP reconciliation

    1. Includes tax expense relating to Swiss tax reform and a loss on the currency remeasurement of the related deferred tax assets, which is recorded within Other (Income) Loss, Net. 12 Note: For more information related to non-GAAP financial measures, refer to the section titled “Supplemental Informa

  13. Slide 13: Non-GAAP reconciliation

    1. Includes tax expense relating to Swiss tax reform and a loss on the currency remeasurement of the related deferred tax assets, which is recorded within Other (Income) Loss, Net. Note: For more information related to non-GAAP financial measures, refer to the section titled “Supplemental Informatio

  14. Slide 14: Contact

    Contact Bennett S. Murphy Senior Vice President Investor Relations bmurphy@amerisourcebergen.com

AmerisourceBergen — Q2 2022 Earnings Presentation on 6ix